Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Atlantis › NPI 1326085424
Hospital

JFK Medical Center Limited Partnership

JFK Medical Center Limited Partnership was paid $18.17M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.

33Billing provider infoJFK MEDICAL CENTER LIMITED PARTNERSHIP
ATLANTIS, FL 33462
33aNPI1326085424assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.17M
24GClaims1,078,209
24DCodes billed244
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#21 of 163
Median peer was paid$4.77M
This provider vs. median3.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018111,398$1.63M
2019230,466$1.93M
2020156,660$1.57M
2021217,271$4.01M
2022207,798$4.89M
2023108,541$2.77M
2024incomplete46,075$1.36M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 19% 49,335 42,012 $3.38M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 49,814 44,978 $3.13M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.5% 24,169 17,944 $1.35M
70450 Computed tomography, head or brain; without contrast material 6.5% 11,617 9,459 $1.18M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.4% 5,453 4,750 $801K
80048 Basic metabolic panel (calcium, ionized) 4.3% 39,659 29,246 $788K
80053 Comprehensive metabolic panel 4.2% 38,768 29,521 $762K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.7% 5,739 4,836 $680K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.5% 8,141 7,451 $637K
G0378 Hospital observation service, per hour 2.4% 25,293 12,276 $436K
96361 Intravenous infusion, hydration; each additional hour 2.1% 3,795 3,356 $390K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.6% 3,160 2,863 $291K
232 more codes
71275 Computed tomographic angiography, chest, with contrast material 1.5% 2,117 $273K
A9270 Non-covered item or service 1.5% 34,532 $266K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.1% 4,146 $194K
71046 Radiologic examination, chest; 2 views <1% 5,383 $143K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 683 $138K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,572 $131K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,801 $126K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,492 $111K
87070 <1% 6,704 $93K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 7,690 $82K
85027 <1% 83,400 $81K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,870 $77K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,093 $77K
87275 <1% 11,546 $71K
73564 <1% 2,188 $70K
71045 Radiologic examination, chest; single view <1% 31,642 $70K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,407 $69K
93976 <1% 2,610 $67K
73610 <1% 1,681 $65K
81001 <1% 25,748 $64K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 17,240 $62K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,704 $60K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,205 $60K
73130 <1% 1,527 $58K
72131 <1% 898 $53K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 867 $53K
81025 <1% 11,405 $52K
80076 <1% 9,602 $49K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 29,320 $48K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,608 $47K
73630 <1% 2,038 $47K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,382 $44K
72125 Computed tomography, cervical spine; without contrast material <1% 4,209 $43K
73110 <1% 1,137 $42K
73030 <1% 1,688 $42K
71250 <1% 857 $38K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 966 $38K
84703 <1% 21,042 $35K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 34,731 $35K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 5,159 $35K
10060 <1% 318 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 32,314 $32K
85610 <1% 14,421 $29K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,955 $29K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,065 $27K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,812 $26K
85730 <1% 12,764 $26K
74018 <1% 534 $26K
72100 <1% 1,209 $25K
84484 <1% 26,654 $25K
J1644 Injection, heparin sodium, per 1000 units <1% 4,780 $24K
00731 <1% 290 $24K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 75 $24K
12001 <1% 363 $23K
81003 <1% 8,372 $23K
73080 <1% 607 $22K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,498 $21K
12011 <1% 305 $20K
82077 <1% 4,239 $20K
C1769 Guide wire <1% 692 $20K
86850 <1% 3,846 $20K
J2704 Injection, propofol, 10 mg <1% 2,022 $19K
97163 <1% 1,274 $19K
S0028 Injection, famotidine, 20 mg <1% 2,402 $19K
93971 <1% 1,436 $17K
J7050 Infusion, normal saline solution, 250 cc <1% 6,074 $16K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,928 $15K
84702 <1% 5,001 $14K
82550 <1% 11,334 $13K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,759 $13K
80047 <1% 534 $13K
83690 <1% 19,754 $13K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 112 $13K
87088 <1% 4,583 $13K
93970 <1% 347 $13K
82553 <1% 4,086 $12K
70486 <1% 917 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,486 $12K
70496 <1% 78 $12K
76830 Ultrasound, transvaginal <1% 855 $12K
87077 <1% 2,476 $11K
99213 Doctor's office visit, returning patient (routine) <1% 115 $11K
86900 <1% 6,062 $11K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 270 $11K
76801 <1% 1,418 $10K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 192 $10K
97162 <1% 557 $10K
73502 <1% 908 $10K
86901 <1% 6,061 $9K
36561 <1% 18 $9K
83880 <1% 6,034 $9K
70491 <1% 92 $8K
87040 <1% 6,185 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,164 $8K
80061 Lipid panel <1% 1,767 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 3,878 $8K
83735 <1% 11,162 $8K
12002 <1% 143 $8K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 64 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,787 $7K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 82 $7K
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,797 $6K
87210 <1% 368 $6K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,759 $6K
96375 Therapeutic injection; each additional sequential IV push <1% 11,376 $5K
87205 <1% 1,335 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,754 $5K
J3490 Unclassified drugs <1% 1,381 $5K
73590 <1% 296 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,057 $5K
J1815 Injection, insulin, per 5 units <1% 5,597 $4K
83605 <1% 5,941 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 41 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,344 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,875 $4K
J2060 Injection, lorazepam, 2 mg <1% 4,701 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,702 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 211 $3K
72040 <1% 94 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 995 $3K
80320 <1% 2,041 $3K
85378 <1% 2,554 $2K
84443 Thyroid stimulating hormone (TSH) <1% 2,984 $2K
87430 <1% 5,072 $2K
82040 <1% 945 $2K
84460 <1% 938 $2K
84155 <1% 948 $2K
82247 <1% 937 $2K
84450 <1% 933 $2K
84075 <1% 935 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,782 $2K
73090 <1% 91 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 362 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,768 $2K
87276 <1% 11,545 $2K
80329 <1% 1,324 $2K
99152 <1% 158 $2K
90714 <1% 1,404 $2K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 3,080 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 915 $1K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 67 $1K
87075 <1% 190 $1K
88342 <1% 1,054 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,790 $1K
87400 <1% 4,665 $1K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 42 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,306 $1K
84100 <1% 3,751 $976.14
76642 <1% 12 $889.11
J3370 Injection, vancomycin hcl, 500 mg <1% 962 $822.10
87186 <1% 291 $685.99
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 994 $659.56
29125 <1% 133 $616.13
72110 <1% 99 $588.91
C9113 Injection, pantoprazole sodium, per vial <1% 654 $582.58
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,855 $563.97
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 51 $561.65
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 16 $561.65
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 964 $556.67
96376 <1% 1,459 $539.33
72170 <1% 18 $496.13
78582 <1% 19 $491.70
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 528 $451.21
99153 Mod sedat endo service >5yrs <1% 42 $439.11
74019 <1% 76 $421.14
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,301 $420.11
80143 <1% 664 $393.81
J3475 Injection, magnesium sulfate, per 500 mg <1% 767 $338.97
36600 <1% 261 $329.11
87807 <1% 2,161 $324.96
70551 Magnetic resonance imaging, brain; without contrast material <1% 35 $318.88
J3486 Injection, ziprasidone mesylate, 10 mg <1% 434 $292.59
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 864 $292.12
82248 <1% 3,642 $248.97
86140 <1% 1,568 $218.55
85651 <1% 1,103 $217.88
82009 <1% 1,139 $217.33
J1630 Injection, haloperidol, up to 5 mg <1% 1,388 $183.64
82805 <1% 18 $182.91
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 759 $176.07
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 103 $167.39
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 32 $166.43
85379 <1% 328 $161.32
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing <1% 20 $160.55
83540 <1% 254 $138.67
83615 <1% 401 $119.21
97116 <1% 412 $103.96
84132 <1% 206 $103.84
85007 <1% 174 $97.57
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 33 $72.48
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 675 $60.92
J0692 Injection, cefepime hydrochloride, 500 mg <1% 709 $50.76
88304 <1% 437 $35.60
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 19 $33.11
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 19 $33.11
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 19 $31.37
82728 <1% 272 $21.50
S5000 Prescription drug, generic <1% 1,487 $14.10
82140 <1% 23 $7.84
83550 <1% 192 $6.88
85018 <1% 91 $3.96
82150 <1% 534 $2.94
J8540 Dexamethasone, oral, 0.25 mg <1% 1,000 $0.96
76937 0% 32 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 155 $0.00
85044 0% 131 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 23 $0.00
87420 0% 358 $0.00
80164 0% 17 $0.00
84439 0% 41 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 22 $0.00
C1788 Port, indwelling (implantable) 0% 17 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 19 $0.00
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 0% 16 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 90 $0.00
J0456 Injection, azithromycin, 500 mg 0% 181 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 189 $0.00
70498 0% 61 $0.00
J7999 Compounded drug, not otherwise classified 0% 187 $0.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 0% 15 $0.00
77001 0% 20 $0.00
45380 Colonoscopy, flexible; with biopsy, single or multiple 0% 54 $0.00
01400 0% 30 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 14 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 92 $0.00
82803 0% 35 $0.00
86920 0% 16 $0.00
A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries 0% 19 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 21 $0.00
86706 0% 27 $0.00
88300 0% 30 $0.00
82607 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHLEMMER, TOM (CFO)